N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers

T. Nukiwa, K. Usui, Y. Saijyo, M. Maemondo, K. Hgiwara, S. Ohta (Sendai, Japan)

Source: Annual Congress 2002 - Lung cancer biology
Session: Lung cancer biology
Session type: Oral Presentation
Number: 226
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Nukiwa, K. Usui, Y. Saijyo, M. Maemondo, K. Hgiwara, S. Ohta (Sendai, Japan). N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers. Eur Respir J 2002; 20: Suppl. 38, 226

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis
Source: Eur Respir J 2002; 20: 703-709
Year: 2002



Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

Expression of p53, Bcl-2 and Bax in non-small cell lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 512s
Year: 2007

IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer
Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016
Year: 2017



Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient
Source: Eur Respir J , 49 (4)  1602149; DOI: 10.1183/13993003.02149-2016
Year: 2017



FGFR1 gene aberrations and FGFR1 protein expression in squamous non-small cell lung cancer (Sq-NSCLC).
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005



Transcriptional regulation of the human osteopontin promoter in non-small cell lung cancer
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

The prognostic value of altered pRb and p53 protein expression in non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 363s
Year: 2003

HER-2/neu oncoprotein expression in nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002

Magnolol can induce apoptosis in non-small cell lung cancer via caspase-independent pathway
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Expression of RASGRF2 in non-small cell lung cancer and its effect of transfection on biological behavior of human NSCLC lines H1299
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 326s
Year: 2006

Hypoxic lung cancer-derived exosome decreases anticancer activity of NK cell by targeting CD226
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019

Her/2 neu and p53 expression in patients with non-small cell lung cancer predict shortened survival
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010